Zhejiang Medicine Co.,Ltd.’s Net Profit Dropped 47.8% in First Three Quarters of 2022

Zhejiang Medicine Co.,Ltd. (浙江医药股份有限公司) (600216.SH) reported a net profit of 357.9 million yuan in the first three quarters of 2022, down 47.8% year-on-year.

Meanwhile, the company posted 6.1 billion yuan in revenue, down 10.1% year-on-year.

At the end of the reporting period, it had 12.4 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 21.9%.